Day 0 – Sept 22, 2026 - ET (Eastern Time, GMT-05:00)
Fundraising Workshop Agenda
Opening Presentation: 3.30pm-4pm
Panel Discussion, 4pm-4.50pm: Traditional VC and Beyond: Exploring Sources of Financing for Biotech Growth
As traditional venture capital becomes more selective and competitive, biotech companies are increasingly turning to alternative financing sources to fund their growth. This panel brings together representatives from non-dilutive funding, venture debt, royalty financing, corporate venture, and other innovative capital sources to discuss how biotechs can diversify their funding strategies and access capital beyond the traditional VC route.
- Strategic Fit & Financial Trade-offs: Choosing the Right Capital for Your Growth Stage
- What Alternative Financiers Evaluate: Eligibility Criteria & Company Readiness
- Designing a Diversified Capital Stack: Integrating Traditional VC with Alternative Sources
Patrick Connolly, Co-Chair of the Business Department, Foley Hoag
Michael Salgaller, Supervisory Technology Analysis & Marketing Specialist, National Institutes of Health
Prativa Joshi, Head of External Ventures, imec
Steven Saltzstein, CEO, FORCE Family Office
- Michael Salgaller - Supervisory Technology Analysis & Marketing Specialist, National Institutes of Health
- Prativa Joshi - Head of External Ventures, imec
- Steven Saltzstein - CEO, FORCE Family Office
- Patrick Connolly - Co Chair Business Development, Foley Hoag